Determination of the Diagnostic Values of Asymmetric Dimethylarginine as an Indicator for Evaluation of the Endothelial Dysfunction in Patients with Rheumatoid Arthritis

Table 1

Patients characteristics examined in the study.

	RA no. 35; Value (M ± SD)	Control healthy group no. 35; Value (M ± SD)
Male/female relation	8/27	18/17
Middle average age (years)	55.57 (±5.68); (39–65)	45.10 (±11.37); (29–65)
Middle duration (time) of disease (month)	42.86 (±44.12); (5–157)	0.00 (±0.00); (0.00-0.00)
Previous therapy with oral corticosteroids; (no. of patients)	0	0
Previus therapy with methotrexate; (no. of patients)	0	0